Shin Poong Pharmaceutical Co., Ltd.

Geum Sil Cho

Jei Man Ryu

Jae Young Lee

Dong Won Lee

Ki Sung Lee

Jin Ho Chung

Jin Hun Park

Chung Ju

Hyun Kyu Chung

Woo Ile Park

Kang Hyeok Lee

Jeiman Ryu

The present invention relates to a use of pyronaridine or a pharmaceutically acceptable salt thereof, and/or artemisinin or a derivative thereof for preventing or treating an epidemic RNA viral infectious disease, and more specifically, to a pharmaceutical composition for preventing or treating an epidemic RNA viral infectious disease, in particular, Coronavirus Disease 2019 (COVID-19), the composition comprising a therapeutically effective amount of pyronaridine or a pharmaceutically acceptable salt thereof, and/or artemisinin or a derivative thereof, together with a pharmaceutically acceptable carrier.

Pharmaceutical composition for preventing or treating epidemic RNA viral infectious disease

The present invention relates to a novel compound having an effect of inhibiting platelet aggregation and a salt thereof and, more specifically, to: a novel platelet aggregation inhibitor specifically inhibiting shear stress-induced platelet aggregation; a pharmaceutical composition containing the same as an active ingredient; and a preparation method therefor.

Compound having effect of inhibiting platelet aggregation and salt thereof, and composition for preventing or treating thrombotic diseases, containing same

Growing community of inventors

Seoul, South Korea

Geum Sil Cho